Can We Improve Antifungal Susceptibility Testing?

Systemic antifungal agents are increasingly used for prevention or treatment of invasive fungal infections, whose prognosis remains poor. At the same time, emergence of resistant or even multi-resistant strains is of concern as the antifungal arsenal is limited. Antifungal susceptibility testing (AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Durand, Charlotte, Maubon, Danièle, Cornet, Muriel, Wang, Yan, Aldebert, Delphine, Garnaud, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461061/
https://www.ncbi.nlm.nih.gov/pubmed/34568095
http://dx.doi.org/10.3389/fcimb.2021.720609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461061/
https://www.ncbi.nlm.nih.gov/pubmed/34568095
http://dx.doi.org/10.3389/fcimb.2021.720609

Ejemplares similares